Cancer Health Treatment Update
Pluvicto Delays Progression of Metastatic Prostate Cancer

The radiopharmaceutical doubled progression-free survival time from six to 12 months.

Dual-Action Drug Produces Positive Results in Patients with Advanced Neuroendocrine Tumors
Cabometyx improved progression-free survival versus placebo in people with neuroendocrine tumors inside or outside the pancreas.
How Epstein-Barr Virus Leads to Tumor Development

EBV causes chromosome breakage that can trigger a cascade of genomic instability leading to tumor growth.

News from ESMO 2023

See all our reports from the European Society for Medical Oncology (ESMO) Congress in Madrid.

 

Cancer Health Fall 2023
Check out our new print edition!
Start Shopping: Enrollment Begins November 1 for Most Obamacare Insurance Plans

Experts recommend all Affordable Care Act policyholders look at next year’s options because prices and networks may have changed.

Advertisement
How SARS-CoV-2 Contributes to Heart Attacks and Strokes

The COVID virus infected coronary arteries and increased inflammation in atherosclerotic plaques.

More News About COVID-19
See all our coverage of COVID-19, including how it affects people living with cancer. For more news about the SARS-CoV-2 coronavirus, visit our sister site, COVID Health.com.

You are receiving this email because you opted in at one of our websites. At your request, this message was sent to newsletter@newslettercollector.com by update@cancerhealth.com. Please remember to add update@cancerhealth.com to your email address book, so that these updates aren't blocked as spam.

To change your subscription information and preferences, please visit your personal preferences page. Or you can unsubscribe completely from this list.

To forward this message, please do not use the forward button of your email application, because this message was made specifically for you only. Instead use the forward page in our newsletter system.

Did you receive this email from a friend? You can subscribe and you will receive our next newsletter directly to your inbox.

Our mailing address is:

Smart + Strong
157 Columbus Avenue, Suite 525
New York, NY 10023

Add us to your address book

Copyright (C) 2023 Smart + Strong 157 Columbus Avenue, Suite 525 New York, NY 10023 USA All rights reserved.
Terms Of Use and Your Privacy.